Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation

Journal of Thoracic and Cardiovascular Surgery

Volumn 114, Issue 2, 1997, Pages 195-202

  Kroshus, T J ^a   Kshettry, V R ^a   Savik, K ^a   John, R ^a   Hertz, M I ^a   Bolman III, R M ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLOGRAFT; ARTICLE; BRONCHIOLITIS; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG INSUFFICIENCY; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; PNEUMONIA; POSTOPERATIVE COMPLICATION; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; TREATMENT PLANNING;

EID: 0030809391     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(97)70144-2     Document Type: Article

References (32)

1. JD Cooper GA Patterson EP Trulock the Washington University Lung Transplant Group Results of single and bilateral lung transplantation in 131 consecutive recipients J Thorac Cardiovasc Surg 107 1994 460 471
2. S Sundaresan EP Trulock T Mohanakumar JD Cooper GA. Patterson Prevalence and outcome of bronchiolitis syndrome after transplantation Ann Thorac Surg 60 1995 1341 1347
3. JD Cooper M Billingham T Egan A working formulation for the standardization of nomenclature and clinical staging of chronic dysfunction in lung allografts J Heart Lung Transplant 12 1993 713 716
4. NL Reinsmoen RM Bolman K Savik K Butters MI. Hertz Are multiple immunopathogenetic events occurring during the development of obliterative bronchiolitis and acute rejection? Transplantation 55 1993 1040 1044
5. RM Bolman SJ Shumway JA Estrin MI. Hertz Lung and heart-lung transplantation: evolution and new applications Ann Surg 214 1991 456 470
6. SA Yousem GJ Berry EM Brunt A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: lung rejection study group J Heart Transplant 9 1990 593 601
7. NL Reinsmoen RM Bolman K Savik K Butters AJ Matas MI. Hertz Improved long-term graft outcome in lung transplant recipients who have donor antigen-specific hyporeactivity J Heart Lung Transplant 13 1994 30 37
8. JD Kalbfleisch RL. Prentice The statistical analysis of failure time data 1980 John Wiley New York 70 117
9. PD. Allison PD Allison Survival analysis using the SAS system: a practical guide. 1996 SAS Institute, Inc Cary (NC) 111 183
10. JD Kalbfleisch RL. Prentice The statistical analysis of failure time data 1980 John Wiley New York 122 140
11. EL Kaplan P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
12. VR Kshettry TJ Kroshus K Savik MI Hertz RM. Bolman Primary pulmonary hypertension as a risk factor for the development of obliterative bronchiolitis in lung allograft recipients Chest 110 1996 704 709
13. MR Kramer C Stoehr JL Whang The diagnosis of obliterative bronchiolitis after heart-lung and lung transplantation: low yield of transbronchial lung biopsy J Heart Lung Transplant 12 1993 675 681
14. CM Burke AJ Morris KD Dawkins Late air flow obstruction in heart-lung transplant recipients Heart Transplant 4 1985 437 440
15. CM Burke J Theodore JC Baldwin Twenty-eight cases of human heart-lung transplantation Lancet 1 1986 517 519
16. BP Griffith IL Paradis A Zeevi Immunologically mediated disease of the airways after pulmonary transplantation Ann Surg 208 1988 371 378
17. AR Glanville JC Baldwin CM Burke Obliterative bronchiolitis after heart-lung transplantation: apparent arrest by augmented immunosuppression Ann Intern Med 107 1987 300 304
18. GA Al-Dossari VR Kshettrey J Jessurun RM. Bolman Experimental large-animal model of obliterative bronchiolitis after lung transplantation Ann Thorac Surg 58 1994 34 40
19. I Paradis JS Dummer J Dauber Risk factors for the development of chronic rejection of the human lung allograft Am Rev Respir Dis 139 1989 A529
20. AJ Duncan JS Duman IL Paradis Cytomegalovirus infection and survival in lung transplant recipients J Heart Lung Transplant 10 1992 638 646
21. SR Duncan IL Paradis JH Dauber SA Youssem RL Hardesty BP. Griffith Ganciclovir prophylaxis for cytomegalovirus infections in pulmonary allograft recipients Am Rev Respir Dis 146 1992 1213 1215
22. TC Merigan DG Renlund S Keay A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation N Engl J Med 326 1992 1182 1186
23. JM Goodrich RA Bowden L Fisher C Keller G Schoch JD. Meyers Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogenic marrow transplantation Ann Intern Med 118 1993 173 178
24. MI Hertz J Jessurun MB King K Savik JJ. Murray Reproduction of the obliterative bronchiolitis lesion after heterotopic transplantation of mouse airways Am J Pathol 142 1993 1945 1951
25. K Bando IL Paradis S Similo Obliterative bronchiolitis after lung and heart-lung transplantation J Thorac Cardiovasc Surg 110 1995 4 14
26. SA Yousem JA Dauber R Keenan IL Paradis A Zeevi BP. Griffith Does histologic acute rejection in lung allografts predict the development of bronchiolitis obliterans? Transplantation 52 1991 306 309
27. C Clelland TW Higgenbottam B Oyulana Histologic prognostic indicators for lung allografts of heart-lung transplants J Heart Lung Transplant 9 1990 177 186
28. JP Scott TW Higgenbottam L Sharples Risk factors for obliterative bronchiolitis in heart-lung transplant recipients Transplantation 51 1991 813 817
29. NL Reinsmoen RM Bolman K Savik KL Butters MI. Hertz Differentiation of Class I– and Class II–directed donor-specific alloreactivity in bronchoalveolar lavage lymphocytes from lung transplant recipients Transplantation 53 1992 181 189
30. H Rabinowich A Zeevi SA Yousem Alloreactivity of lung biopsy and bronchoalveolar derived lymphocytes from pulmonary transplant patients: correlation with acute rejection and bronchiolitis obliterans Clin Transplant 4 1990 376 384
31. A Zeevi H Rabinowich SA Yousem Presence of donor-specific alloreactivity in histologically normal lung allografts is predictive of subsequent bronchiolitis obliterans Transplant Proc 23 1991 1128 1129
32. NL Reinsmoen AJ. Matas Improved late renal transplant outcome correlates with the development of in vitro antigen-specific reactivity Transplantation 55 1993 1017 1023